Registry for Severe ROP and Treatment on Visual Outcomes
NCT ID: NCT01559571
Last Updated: 2020-06-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
324 participants
OBSERVATIONAL
2012-05-31
2020-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improve Screening Criteria for Retinopathy of Prematurity in Two French Center
NCT05152862
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
NCT06612541
Evaluation of Refractive Status and Ophthalmological Problems of Prematurity
NCT01045616
Feasibility of Nurse-led Retinal Imaging for Retinopathy of Prematurity Screening Employing the Optos California
NCT06063863
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
NCT06517940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inborn and those admitted within 7 days of birth
* Infant with a diagnosis of stage 2 ROP or higher
* Site ability to plan close ophthalmological follow-up due to significant and persistent ROP
* Parents must agree to report outcomes following each ophthalmological visit and overall outcomes for up to five (5) years of age
* Ability to obtain follow-up data on outcomes if the child is transferred to another facility
* No known major congenital anomalies
Exclusion Criteria
* Parents unwilling to participate in follow-up
* Major congenital anomalies
7 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pediatrix
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reese H Clark, MD
Role: PRINCIPAL_INVESTIGATOR
Pediatrix
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Hospital of South Bend
South Bend, Indiana, United States
Summerlin Hospital Medical Center
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tolia VN, Ahmad KA, Jacob J, Kelleher AS, McLane N, Arnold RW, Clark RH; MEDNAX ROP Registry Investigators. Two-Year Outcomes of Infants with Stage 2 or Higher Retinopathy of Prematurity: Results from a Large Multicenter Registry. Am J Perinatol. 2020 Jan;37(2):196-203. doi: 10.1055/s-0039-1694983. Epub 2019 Sep 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDX-01-011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.